Group 1 - The core viewpoint of the article highlights that Yidu Tech (02158) has demonstrated a strong commitment to boosting market confidence through significant share buybacks, with over 1.46 million shares repurchased at approximately HKD 5.6 per share, totaling over HKD 8 million on February 3 [1] - As of February 3, Yidu Tech has executed share buybacks for seven consecutive trading days, accumulating a total buyback amount exceeding HKD 22.7 million [1] - Huajin Securities reports that AI technology is increasingly penetrating the entire healthcare industry chain, enhancing efficiency and quality across drug development, clinical trials, and treatment processes, supported by government policies promoting AI applications in healthcare [1] Group 2 - Yidu Tech, as a veteran player in AI healthcare, is making steady progress in its business, recently implementing innovative diagnostic assistants and health management systems in cities like Chongqing and Shenzhen [1] - Market analysis suggests that the continuous share buyback operations, combined with signals of fundamental improvement and progress in diverse business areas, reinforce market perceptions of the company's strategic execution efficiency and long-term investment value [1]
医渡科技(02158)连续7日回购 累计斥资超2270万港元